Please assess the completion status of the following clinical trial:

Trial Title: 0.9% NaCl/Dextrose 5% vs 0.45% NaCl/Dextrose 5% as Maintenance Intravenous Fluids in Critically Ill Children

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 1 month to 18 years~* ICU stay \>24 hours~* Normal seric sodium (135 - 145 mEq/L).~* Requirement of IV maintenance solutions \>80% total fluids intake~Exclusion Criteria:~* Patients with diagnoses of renal failure (serum creatinine \>1 g/dl in \<3 years old children, \>1,5 in \>3 years), hepatic failure with ascitis and portal hypertension, adrenal failure, nephrotic - nephritic syndrome, Kawasaki disease, sickle cell anemia, Syndrome of inappropriate antidiuretic hormone secretion, diabetes insipidus,metabolic disease.~* Diuretics use in the first 48 hours thereafter indicated IV solutions.~* Plasma glucose is \>200 mg%.~* Any patients requiring IV fluids therapy different that maintenance (total parenteral nutrition, hyperhydration).

- Gender: ALL
- Minimum Age: 1 Month
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- Hypotonic (Type: ACTIVE_COMPARATOR): Subjects in this arm will receive 0.45% NaCl/5% dextrose intravenous maintenance fluids.
- Isotonic (Type: EXPERIMENTAL): Subjects in this arm will receive 0.9% NaCl/5% dextrose intravenous maintenance fluids.

Based on this trial design, predict the completion outcome and termination type (if applicable).